Drugs Used to Alleviate Symptoms with Life Shortening as a Possible Side Effect: End-of-Life Care in Six European Countries
Authors:
- Johan BilsenJBJohan Bilsen
- Michael NorupMNMichael Norup
- Luc DeliensLDLuc Deliens
- Guido MiccinesiGMGuido Miccinesi
- Gerrit van der WalGWGerrit van der Wal
- Rurik LöfmarkRLRurik Löfmark
- Karin FaisstKFKarin Faisst
- Agnes van der HeideAHAgnes van der Heide
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 31 (2) , 111-121
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- End-of-life decision-making in six European countries: descriptive studyThe Lancet, 2003
- National survey of medical decisions at end of life made by New Zealand general practitionersBMJ, 2003
- Equianalgesic Dose Ratios for OpioidsJournal of Pain and Symptom Management, 2001
- Accuracy in Equianalgesic DosingJournal of Pain and Symptom Management, 2001
- Management of Pain and Spinal Cord Compression in Patients with Advanced CancerAnnals of Internal Medicine, 1999
- A National Survey of Physician-Assisted Suicide and Euthanasia in the United StatesNew England Journal of Medicine, 1998
- The Rule of Double Effect — A Critique of Its Role in End-of-Life Decision MakingNew England Journal of Medicine, 1997
- Euthanasia, Physician-Assisted Suicide, and Other Medical Practices Involving the End of Life in the Netherlands, 1990–1995New England Journal of Medicine, 1996
- The WHO Analgesic Ladder for Cancer Pain ManagementJAMA, 1995
- Opiophobia and cancer pain in EuropeThe Lancet, 1993